SGH Medical Pharma company
Inside SGH Medical Pharma
Watch our corporate video to discover how we bring together quality, innovation, and precision in every product we create.
Our capabilities
Thanks to advanced technologies and deep regulatory expertise, SGH Medical Pharma offers both standard products and fully customized solutions. Our team supports clients in turning their ideas into reality.
Our core competencies include:
Product and process engineering
Our R&D team develops innovative, user-friendly medical and pharmaceutical devices.
We offer:
- Ergonomic and usability studies
- Cost-effective design strategies
- Lifecycle impact analysis
- Prototyping using Fused Deposition Modeling (FDM)
Each solution is made to be efficient, affordable, and sustainable.
Manufacturing and supply management
Thanks to Rovipharm’s expertise in cleanroom production and Stiplastics’ know-how in automation, we provide top-quality plastic solutions using:
- ISO 7 and ISO 8 certified cleanrooms
- Fully automated assembly workshops
- Complete packaging and logistics lines
These facilities ensure high quality and efficient global delivery.
Regulatory expertise
In a complex regulatory world, we help clients stay compliant.
We have:
- 135 CE-marked devices
- A Drug Master File submitted to the FDA
We manage all required documents and help products enter markets smoothly and safely.
Our values
Innovation
Effective and intuitive devices with a global and sustainable approach
We rely on the excellence of our industrial processes to innovate and design usable, intuitive, and effective medical devices. Our vision is both global and technological, guided by a sustainable and ethical approach to create real value for patients and healthcare professionals alike.
Agility
A decentralized model to adapt quickly and respond to market needs.
With a decentralized and multisite organization, we remain highly responsive and adaptable—whatever the demand or context. Our agility fuels our capacity to deliver, ensuring continuity, reliability, and constant innovation even in changing environments.
Willingness
Pushing boundaries to create meaningful products, enhance performance, and respect the environment.
We believe everything is possible when we work together. Thanks to our collaborative mindset and shared ambition, our teams consistently push the limits to create more useful innovations, improve product performance, and foster customer-driven solutions—all while respecting people and the environment.
Our strategy
The aim of SGH Medical Pharma’s ambitious development project is to build a European group, specialising mainly in drug administration, respiratory conditions and diagnostics.
SGH Medical Pharma is aiming for turnover of €100 million, which will enable it to reach the critical mass sought by our laboratory customers and manage the structural costs associated with regulatory requirements. I attach critical importance to compliance with laws, regulations and universal ethical principles. Our corporate social responsibility policy reflects our commitment through the rules and ethical principles it supports and protects, and to which it is actively committed.
Promoting this culture and demanding compliance is, in our view, essential: we must be able to guarantee that we always act with integrity.
We will therefore increase our turnover alongside, the organisation’s clear desire to incorporate social and environmental considerations into its decision-making but we will also be well equipped to account for the impact of its decisions and activities on society and the environment.
SGH Medical Pharma was forged from the expertise of Rovipharm, and Stiplastics —united by over 40 years of plastics processing know-how.
Our history: from Rovipharm and Stiplastics to SGH Medical Pharma
-
1984
The ROVIP GROUP diversifies its business in healthcare, in a new entity to become ROVIPHARM
-
1985
Creation of STIPLASTICS
-
1995
Creation of ESKISS
-
2003
STIPLASTICS and ROVIP both get ISO 13485
-
2006
Creation of ROVIPHARM
-
2017
STIPLASTICS builds a new 10,000m² manufacturing plant in Saint-Marcellin
-
2018
Creation of SGH HEALTHCARING, reuniting STIPLASTICS, ESKISS and ROVIPHARM
Involvement of Merieux Equity Partners and GIMV
-
2019
Shift to in vitro diagnostics with first strategic agreements as “Contract manufacturer”
Pharmapack Award for IQ DOSE
-
2021
New ISO 8-7 cleanroom at Rovipharm site, 100% automated and DNA/RNA free.
-
2022
First batches of filtered pipette tips
SGH Healthcaring becomes SGH Medical Pharma
-
2023
New cleanroom
-
2024
STIPLASTICS site will become a Pharmaceutical Establishment
600m² plant extension
Plant extension in Tunisia
Our locations
With over 250 employees, SGH Medical Pharma operates across three strategic sites in France and Tunisia. Whether you need a standard product or a tailor-made solution, our teams are here to support your success.
Tour Oxygène
10 – 12 Boulevard Vivier Merle
69003 Lyon, France
62 chemin des Plantées
38160 Saint-Marcellin, France
Tel. : +33 4 76 38 08 44
86 route du Plan d’eau
01370 Val-Revermont, France
Tel. : +33 4 74 42 39 39
Parc Naturopôle
03800 Saint-Bonnet-de-Rochefort, France
Tel. : +33 4 70 58 85 51
5 rue de la Chimie
Z.I Sidi Rezig
2033 Megrine, Tunisia
Careers at SGH Medical Pharma
Join us in shaping the future of medical innovation. Explore our current job opportunities and become part of a dynamic, purpose-driven team.